Latest filing published 20 Mar 2023 for Axogen, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Bradley Ottinger: trading record in brief
All filings by Bradley Ottinger on record concern Axogen, Inc., in the capacity of senior executive. In total, 8 filings cover trades dated from 16 March 2022 to 16 March 2023.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 20 March 2023, the filings show a share grant worth €6,236 in Axogen, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Bradley Ottinger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,900 shares0Common StockSEC:0000805928-23-000026:0
- 15,500 shares0Common StockSEC:0000805928-22-000066:0
- 2,563 shares0Common StockSEC:0000805928-22-000032:0
3 of 3 declarations
